31/07/2018 - Campus Can Ruti, Innovation, Institutional, Research

The Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) opens for business

In June this year the new Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) started its normal working activities.  Located at the highest point of the campus, the CMCiB is a centre promoted by the Germans Trias i Pujol Research Institute (IGTP) and dedicated to biomedical research and training.  The centre is an important addition to scientific infrastructures in southern Europe and is the only one in Spain, it has been set up to become a reference in comparative medicine, bioimaging and computational models with a clear remit to promote alternative research models and methods

29/06/2018 - Campus Can Ruti

Huge turnout for the first Can Ruti PhD Day

"Organized by us, for us," has been the catchphrase for the first Campus Can Ruti PhD Day.   The event took place on Friday 29 June with a traditional scientific conference format and it provided a meeting point for all the PhD students on Campus Can Ruti.   The idea came from five pre-doctoral researchers, carrying out their respective theses in different institutions on the campus, who made up the first Campus Can Ruti doctoral students' committee.

11/06/2018 - Campus Can Ruti, Research

Beatriz Mothe awarded ex aequo at the 10th Research Symposium of the ICS

The 10^th Research Symposium of the Catalan Health Institute (ICS) and the 11^th Research Symposium of the Primary Health Care Research Institute (IDIAP) Jordi Gol were held jointly on 7 June 2018.  The central theme of the event was the use of large clinical data bases to carry out research to improve health.

07/06/2018 - Campus Can Ruti, Research

Three projects from Campus Can Ruti in the 19th Simposium of La Marató

The TV3 La Marató Foundation has published the results of the cancer research supported by Funds from the marathon campaign of 2012.   Of the 79 research groups who participated in 42 projects financed by this edition of the programme three are from the IGTP.

04/03/2018 - Campus Can Ruti

The 2018 Fun Run for Minority Diseases doubles its money with twice as many competitors as last year

The seventh edition of the Charity Fun Run for Minority Paediatric Diseases was a resounding success this year, with twice as many runners as 2017.  In all 700 participants completed the different routes and enjoyed a family fun day in Badalona.

05/03/2018 - Campus Can Ruti, Research

Reusable water bottles in an appeal coinciding with World Kidney Day

Today and during all of this week reusable water bottles will be on sale at three supermarkets of the Sorli chain in Badalona.  Funds from the sales will support research into kidney disease.   The event is part of the celebration of World Kidney Day, which takes place on 8 March.

28/02/2018 - Campus Can Ruti, Outreach

Can Ruti 'shows its rare' on Rare Disease Day

Many activities have taken place this week on Campus Can Ruti to celebrate the International Rare Disease Day on the last day of February.

09/02/2018 - Campus Can Ruti, Research

Julia García Prado, new IGTP Scientific Director

Dr. García Prado, leader of the Viral Immune Evasion and Vacciones (VIRIEVAC) at the IrsiCaixa AIDS Research Institute will combine the new position with the leadership of her group, focused on the design of new strategies against HIV. Manel Puig, General Director of the IGTP, has presented the new organizational chart during the presentation of the Research Agenda 2018, together with the new challenges for the coming years.

06/02/2018 - Campus Can Ruti, Research

Vote for Dr. Vavouri in the Vanguardia de la Ciencia award

Tanya Vavouri, researcher at the IGTP and Josep Carreras Leukemia Research Institute is one of the nominees for the Vanguardia de la Ciencia award, for the study showing that environment affects genetics and can be retained for generations. The vote is open to everyone, scientist or not, until February 28. 

04/12/2017 - Campus Can Ruti

A trial in advanced colorectal cancer opens the door to a future blood test to predict the most efficient treatment for reducing metastasis

The study, published in 'Annals of Oncology' aimed to demonstrate that choosing the treatment regime based on genetic variants could improve the prognosis of patients with advanced colorectal cancer. Although this primary objective was not achieved, the trial did show that a blood test can be used to predict the most efficient treatment to reduce metastasis.